nt10q_usbio.htm
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
DC 20549
FORM
12b-25
NOTIFICATION
OF LATE FILING
o Form
10-K o Form
20-F o Form
11-K x Form
10-Q o Form
10-D o Form
N-SAR o Form
N-CSR
For the
period ended: May 31,
2008
o Transition
Report on Form 10-K
o Transition
Report on Form 20-F
o Transition
Report on Form 11-K
o Transition
Report on Form 10-Q
o Transition
Report on Form N-SAR
For the
transition period ended:
Nothing
in this form shall be construed to imply that the Commission has verified any
information contained herein.
If the
notification relates to a portion of the filing checked above, identify the
Item(s) to which the notification relates:
Part
I-Registrant Information
|
Full
name of Registrant:
Former
name if Applicable:
Address
of Principal Executive Office ( Street and Number ):
City,
State and Zip Code:
|
US
BIODEFENSE, INC.
300
State Street East, Suite 226
Oldsmar,
FL 34677
|
Part
II-Rules 12b-25(b) and (c)
If the
subject report could not be filed without unreasonable effort or expense and the
registrant seeks relief pursuant to Rule 12b-25(b), the following should be
completed. (Check box if appropriate)
|
x
|
(a)
The reason described in reasonable detail in Part III of this
form could not be eliminated without unreasonable effort or
expense;
|
|
x
|
(b)
The subject annual report, semi-annual report, transition
report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or
portion thereof, will be filed on or before the fifteenth calendar day
following the prescribed due date; or the subject quarterly report or
transition report on Form 10-Q or subject distribution report on Form
10-D, or portion thereof, will be filed on or before the fifth calendar
day following the prescribed due date; and
|
|
o
|
(c)
The accountant's statement or other exhibit required by Rule
12b-25(c) has been attached if
applicable.
|
Part
III-Narrative
State
below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR,
N-CSR, or the transition report or portion thereof, could not be filed within
the prescribed time period.
The
registrant requires additional time to complete the auditor’s review of the
registrant’s financial statements in order to complete the 10-QSB prior to
filing. The registrant expects to file its Form 10-QSB within five calendar days
of the prescribed due date.
Part
IV - Other Information
(1)
Name and telephone number of person to contact in regard to this
notification:
|
Scott
Gallagher
|
727
|
417-7807
|
|
(Name)
|
(Area
Code)
|
(Telephone
Number)
|
(2)
Have all other periodic reports required under Section 13 or 15(d) of the
Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of
1940 during the preceding 12 months or for such shorter period that the
registrant was required to file such report(s) been filed? If answer is no,
identify report(s). x Yes o| No
(3)
Is it anticipated that any significant change in results of
operations from the corresponding period for the last fiscal year will be
reflected by the earnings statements to be included in the subject report or
portion thereof? o Yes x No
If so,
attach an explanation of the anticipated change, both narratively and
quantitatively, and, if appropriate, state the reasons why a reasonable estimate
of the results cannot be made.
US Biodefense,
Inc.
(Name of
Registrant as Specified in Charter)
has
caused this notification to be signed on its behalf by the undersigned thereunto
duly authorized.
|
Date:
July 14, 2008
|
By:
/s/ Scott Gallagher
Scott
Gallagher
Chief
Executive Officer
|
INSTRUCTION:
The form may be signed by an executive officer of the registrant or by any other
duly authorized representative. The name and title of the person signing the
form shall be typed or printed beneath the signature. If the statement is signed
on behalf of the registrant by an authorized representative (other than an
executive officer), evidence of the representative's authority to sign on behalf
of the registrant shall be filed with the form.
ATTENTION
Intentional
misstatements or omissions of fact constitute Federal Criminal Violations (See
18 U.S.C. 1001).